We are proud to announce that PhenoPath is now part of AmeriPath.
CD1a, CD3, CD33, CD34, CD45, CD99, HLA-DR, TdT
This tube is designed to assess surface CD1a and nuclear TdT in the setting of expanded immature T cell populations, and includes the following antibodies: CD45, TdT, CD1a, CD3, CD34, CD33, CD99, and HLA-DR.
Disease State: Precursor T-Lymphoblastic Lymphoma/Leukemia (T-ALL)
CPT Code(s): 88185x8 (reference only; CPTs may vary)
Turnaround Time: Physician will be contacted by 9:00 PM PST the day of receipt for acute/life threatening conditions; next business day for routine flow cases.
• Peripheral blood, Preferred: 3 ml in sodium heparin (green top) / Acceptable: 3 ml in EDTA (purple top) - OR -
• Bone marrow aspirate, Preferred: 1-2 ml in sodium heparin (green top) / Acceptable: 1-2 ml in EDTA (purple top) - OR -
• Tissue: Finely minced tissue in RPMI transport media - OR -
• Body fluids: In RPMI transport media